https://doi.org/10.1140/epjs/s11734-022-00753-w
Regular Article
Spectral entropy provides separation between Alzheimer’s disease patients and controls: a study of fNIRS
1
Research Unit of Health Sciences and Technology, University of Oulu, 90100, Oulu, Finland
2
Department of Electrical Engineering, Petra Christian University, 60236, Surabaya, Indonesia
3
Opto-Electronics and Measurement Technique Research Unit, University of Oulu, 90570, Oulu, Finland
4
Department of Radiology, Oulu University Hospital, 90100, Oulu, Finland
Received:
3
October
2022
Accepted:
28
November
2022
Published online:
19
December
2022
Functional near-infrared spectroscopy (fNIRS) is commonly used as a non-invasive tool to measure cerebral neurovascular dynamics. Its potential for diagnostics of various brain disorders has been already demonstrated in many recent studies, including Alzheimer’s disease (AD). fNIRS studies are usually based on comparing hemoglobin measurements at baseline and during a specific task. At present, many proposed methods using fNIRS to diagnose AD involve certain tasks, which may be challenging for the elderly and patients with cognitive decline. Here, we propose a method to characterize AD patients and control in resting state, by applying spectral entropy (SE) analysis on oxyhemoglobin and deoxyhemoglobin, HbO and HbR, respectively, and total hemoglobin (HbT) based on fNIRS signals measured from the left and right sides of the forehead. We applied SE to very low frequency (VLF) (0.008–0.1 Hz), respiratory (0.1–0.6 Hz), and cardiac (0.6–5 Hz) bands to find out which band delivered the optimum result. Next, a t test with 0.05 significant level was performed to compare SE values of AD patients and controls. Results from the VLF band looked promising as SE values from AD patients were always significantly higher than those from controls. In addition, this phenomenon was consistent for both sides of the forehead. However, significant differences in SE values in the respiratory band were found from the left hemisphere only, and in the cardiac band from the right hemisphere only. SE value from the VLF band supports a strong argument that it provides good predictability related to the development of AD. We demonstrated that SE of brain fNIRS signal can be an useful biomarker for Alzheimer’s disease pathology.
© The Author(s) 2022
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.